RJA
CLMT icon

Raymond James & Associates’s Calumet Specialty Products CLMT Stock Holding History

Raymond James & Associates’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-572,057
Closed -$9.18M – 4013
2024
Q2 		$9.18M Buy
572,057
+67,689
+13% +$1.07M 0.01% 1213
2024
Q1 		$7.49M Buy
504,368
+50,008
+11% +$797K 0.01% 1319
2023
Q4 		$8.12M Buy
454,360
+128,693
+40% +$2.09M 0.01% 1238
2023
Q3 		$6.22M Buy
325,667
+26,585
+9% +$460K 0.01% 1325
2023
Q2 		$4.74M Buy
299,082
+1,261
+0.4% +$20.8K ﹤0.01% 1515
2023
Q1 		$5.18M Buy
297,821
+35,689
+14% +$634K ﹤0.01% 1437
2022
Q4 		$4.42M Sell
262,132
-44,700
-15% -$721K ﹤0.01% 1479
2022
Q3 		$3.93M Sell
306,832
-50,102
-14% -$719K ﹤0.01% 1538
2022
Q2 		$3.71M Buy
356,934
+48,879
+16% +$650K ﹤0.01% 1605
2022
Q1 		$4.19M Buy
308,055
+40,480
+15% +$596K ﹤0.01% 1634
2021
Q4 		$3.53M Buy
267,575
+56,514
+27% +$711K ﹤0.01% 1779
2021
Q3 		$1.67M Buy
211,061
+59,809
+40% +$412K ﹤0.01% 2226
2021
Q2 		$1.04M Buy
151,252
+106,879
+241% +$659K ﹤0.01% 2565
2021
Q1 		$271K Buy
44,373
+3,487
+9% +$14.6K ﹤0.01% 3423
2020
Q4 		$128K Buy
+40,886
New +$143K ﹤0.01% 3516
2020
Q1 		– Sell
-10,142
Closed -$37K – 3534
2019
Q4 		$37K Sell
10,142
-2,898
-22% -$10K ﹤0.01% 3572
2019
Q3 		$47K Sell
13,040
-3,287
-20% -$14.1K ﹤0.01% 3475
2019
Q2 		$68K Sell
16,327
-372
-2% -$1.49K ﹤0.01% 3464
2019
Q1 		$59K Sell
16,699
-300
-2% -$998 ﹤0.01% 3462
2018
Q4 		$38K Sell
16,999
-10,748
-39% -$44.3K ﹤0.01% 3408
2018
Q3 		$178K Sell
27,747
-8,219
-23% -$58.3K ﹤0.01% 3329
2018
Q2 		$268K Sell
35,966
-167
-0.5% -$1.25K ﹤0.01% 3094
2018
Q1 		$255K Sell
36,133
-2,020
-5% -$14.9K ﹤0.01% 2995
2017
Q4 		$294K Buy
38,153
+7,146
+23% +$59.6K ﹤0.01% 2845
2017
Q3 		$259K Buy
31,007
+9,042
+41% +$56.3K ﹤0.01% 2877
2017
Q2 		$93K Sell
21,965
-3,425
-13% -$13.7K ﹤0.01% 3123
2017
Q1 		$96K Sell
25,390
-14,940
-37% -$59.1K ﹤0.01% 3074
2016
Q4 		$161K Sell
40,330
-179,204
-82% -$731K ﹤0.01% 2936
2016
Q3 		$990K Sell
219,534
-4,054
-2% -$20.9K ﹤0.01% 1888
2016
Q2 		$1.1M Sell
223,588
-1,060
-0.5% -$6.01K ﹤0.01% 1689
2016
Q1 		$2.64M Buy
224,648
+5,561
+3% +$77.3K 0.01% 1126
2015
Q4 		$4.36M Buy
219,087
+5,327
+2% +$132K 0.02% 866
2015
Q3 		$5.19M Buy
213,760
+135,119
+172% +$3.51M 0.02% 730
2015
Q2 		$2M Sell
78,641
-8,931
-10% -$237K 0.01% 1315
2015
Q1 		$2.11M Buy
87,572
+64,277
+276% +$1.63M 0.01% 1210
2014
Q4 		$522K Buy
23,295
+535
+2% +$13.9K ﹤0.01% 1919
2014
Q3 		$625K Sell
22,760
-8,100
-26% -$245K ﹤0.01% 1757
2014
Q2 		$981K Buy
30,860
+11,186
+57% +$333K 0.01% 1504
2014
Q1 		$508K Buy
19,674
+200
+1% +$5.46K ﹤0.01% 1779
2013
Q4 		$507K Buy
19,474
+4,991
+34% +$139K ﹤0.01% 1667
2013
Q3 		$395K Sell
14,483
-2,432
-14% -$76.4K ﹤0.01% 1680
2013
Q2 		$615K Buy
+16,915
New +$608K 0.01% 1414

Other funds holding CLMT

WDOM
Wasserstein Debt Opportunities Management New York $189M AUM 169.75% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return

Raymond James & Associates's CLMT Position: Q3 2024 in Review

Raymond James & Associates sold out of Calumet Specialty Products (CLMT) in Q3 2024, closing a stake of 572,057 shares — an estimated $9.18M sold.

Raymond James & Associates first reported a position in CLMT in Q2 2013 and held it in 42 quarters. The position peaked at $9.18M in Q2 2024. 91 funds tracked by Wall St. Rank hold CLMT as of Q3 2024.

  • Raymond James & Associates reported no remaining Calumet Specialty Products position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 572,057 Calumet Specialty Products shares in Q3 2024, an estimated $9.18M.
  • Raymond James & Associates first reported a position in Calumet Specialty Products in Q2 2013 and held it in 42 quarters.
  • Raymond James & Associates's Calumet Specialty Products position peaked at $9.18M in Q2 2024.
  • 91 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.